Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Amgen
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Charite University, Berlin, Germany